Krishnan Nandabalan
InvestorFounderCEO, Founder, & President, InveniAI at AIF · Chief Executive Officer, President and Chairman at Invea Therapeutics, Inc.
Branford, Connecticut, United States
FoundedInvea Therapeutics, Inc.
Find your path to Krishnan
245 people in our graph share verified history with Krishnan — schools, employers, funds. One of them is your warm intro.
About
Krishnan Nandabalan is President, Chairman, and CEO of AlphaMeld Corporation and President and CEO of InveniAI Corporation, a technology spinout focused on applying big data analytics and machine learning to drug and target discovery. With over two decades in pharmaceutical and biotechnology R&D, operations, and business development, he has completed licensing and M&A transactions with major industry players and previously served as VP of Corporate Development at Genaissance Pharmaceuticals and Group Leader of Functional Genomics at CuraGen Corporation. He holds a Ph.D. in Biochemistry and Molecular Biology from the Indian Institute of Science, completed a postdoctoral fellowship at Yale University, and has 12 issued patents and publications in peer-reviewed journals including Cell and Science.
Chief Executive Officer, President and Chairman at Invea Therapeutics, Inc.
Intro paths
In turn, Krishnan can intro founders to Invea Therapeutics, Inc.'s investors below.
Invea Therapeutics, Inc.'s investors · 1
Experience
- AlphaMeld CorporationPresident, Chairman, and CEO of AlphaMeld Corporationcurrent2024 — presentGuilford, Connecticut, United States
- AlphaMeld CorporationBoard Membercurrent2017 — presentGuilford, Connecticut, United States
- Invea TherapeuticsFounder, Chairman, President, CEOcurrent2021 — presentGuilford, Connecticut, United States
- InveniAI LLCPresident, CEO, and Foundercurrent2017 — presentGuilford, Connecticut, United States
- BioXcel Therapeutics, Inc.Board Member2017 — 2023New Haven, Connecticut, United States
- BioXcel CorporationPresident and Co-Founder2005 — 2023Guilford, Connecticut, United States
- BioXcel CorporationBoard Member2005 — 2023Guilford, Connecticut, United States
Skills & more
From Krishnan's professional profile.
Colleagues at AIF
Frequently asked questions
- Who is Krishnan Nandabalan?
- Krishnan Nandabalan is President, Chairman, and CEO of AlphaMeld Corporation and President and CEO of InveniAI Corporation, a technology spinout focused on applying big data analytics and machine learning to drug and target discovery. With over two decades in pharmaceutical and biotechnology R&D, operations, and business development, he has completed licensing and M&A transactions with major industry players and previously served as VP of Corporate Development at Genaissance Pharmaceuticals and Group Leader of Functional Genomics at CuraGen Corporation. He holds a Ph.D. in Biochemistry and Molecular Biology from the Indian Institute of Science, completed a postdoctoral fellowship at Yale University, and has 12 issued patents and publications in peer-reviewed journals including Cell and Science.
- Where does Krishnan Nandabalan work?
- Krishnan Nandabalan is Chief Executive Officer, President and Chairman of Invea Therapeutics, Inc. and CEO, Founder, & President, InveniAI at AIF.
- What companies did Krishnan Nandabalan found?
- Krishnan Nandabalan founded Invea Therapeutics, Inc..
- Where did Krishnan Nandabalan go to school?
- Krishnan Nandabalan studied at Yale University (Post-Doctoral Fellow, Yeast Genetics); University of Kentucky (Post Doctoral Fellow).
Founder mafias
Yale University mafia373
Also came through, then founded or led a company.
+ 366 more
University of Kentucky mafia27
Also came through, then founded or led a company.
+ 20 more
AIF mafia7
Also came through, then founded or led a company.
Same school
Also attended Yale University1,080
+ 1,074 more
Also attended University of Kentucky113
+ 107 more
